Alvotech was founded in 2013, with the clear mission to become a global leader in
Biogenerics, defined as differentiated, high-quality, cost-controlled biosimilars. We have
pursued this goal by creating a fully-integrated specialty company in control of every value
adding development step from cell line development to commercial manufacturing of the
product.
Our in-house development and manufacturing platform located at four sites across Europe
drives timely development of a strong and differentiated portfolio, while our state-of-the-art
flexible manufacturing facility, located in Reykjavik Iceland, ensures high quality and cost-effective production.
We are passionate about what we have created and our stated purpose of transforming
access to life-altering therapies for patients across the globe. We believe in focus and
specialization and each of our 250 professionals share our passion and pride to be part of
this mission.
We are dedicated to making people's lives better by improving access to and lowering cost of care.
Because if there is a cure it should be available to everyone.